501 AZD2796, a myeloid checkpoint inhibitor targeting LILRB2 that promotes pro-inflammatory responses by macrophages and enhances T cell anti-tumor activity von Jones, Des C, Irving, Lorraine, Dudley, Becki, Wolny, Marcin, Blümli, Seraina, Chatzopoulou, Ellie, Sandercock, Alan, Bowyer, Georgina, Pryts, Stacy, Mulgrew, Kathy, Dovedi, Simon, Arnaldez, Fernanda, Cobbold, Mark

Volltext